Table 2.
Control | Placebo | EMLA | Vapocoolant | |
---|---|---|---|---|
VAS | 28.8±17.9 (0-75) | 33.4±19.5 (0-77) | 10.7±10.6 (0-44)*#§ | 14.0±12.4 (0-53)# § |
Moderate pain VAS> 30 mm |
20 (48.8%) | 23 (56.1%) | 4 (9.8%)#§ | 4 (9.8%)#§ |
Severe pain VAS> 54 mm |
5 (12.2%) | 8 (19.5%) | 0 (0%)#§ | 0 (0%)#§ |
VAS: 0mm-100mm. Data are presented as Mean± SD (range) or number of patients (percentage). *p=0.00 compared to vapocoolant, # p=0.00 compared to control, § p=0.00 compared to placebo.